Walker M C, Phillips-Quagliata J M
J Immunol. 1979 Apr;122(4):1544-7.
Resistance to the BALB/c plasmacytoma MPC-11 by F1 hybrids between BALB/c and four C57BL/10 congenic resistant strains was abrogated or reduced by 450 rads total body irradiation but was unaffected by intravenous injection of 3 to 4 mg of silica. The results are consistent with the idea that hybrid resistance to MPC-11 depends on an active immune response and is different from Hh-1 controlled hybrid resistance.
BALB/c与四个C57BL/10同源抗性品系之间的F1杂种对BALB/c浆细胞瘤MPC-11的抗性,经450拉德全身照射后被消除或降低,但静脉注射3至4毫克二氧化硅对其没有影响。这些结果与以下观点一致,即杂种对MPC-11的抗性取决于活跃的免疫反应,并且不同于Hh-1控制的杂种抗性。